ClinVar Miner

Submissions for variant NM_001875.5(CPS1):c.2549G>A (p.Arg850His)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000816596 SCV000957113 pathogenic Congenital hyperammonemia, type I 2018-12-28 criteria provided, single submitter clinical testing This sequence change replaces arginine with histidine at codon 850 of the CPS1 protein (p.Arg850His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs767694281, ExAC 0.002%). This variant has been observed in individual(s) with carbamoylphosphate synthetase 1 deficiency (PMID: 15617192, 22575620, 27150549). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant has been reported to affect CPS1 protein function (PMID: 24813853). This variant disrupts the p.Arg850 amino acid residue in CPS1. Other variant(s) that disrupt this residue have been observed in individuals with CPS1-related conditions (PMID: 17310273), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.